Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females

NCT07225335 is registered in ClinicalTrials.gov with TSI Group LTD as lead sponsor.

NCT NCT07225335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07225335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females
Lead sponsor
TSI Group LTD
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2025
Completion date
December 19, 2025
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

creatine absorption in healthy adults